Switzerland, consistently ranked no.1 in innovation, is widely known for innovation in big pharma with the presence of eminent pharma and life-sciences companies like Novartis, Roche, Lonza, Ferring Pharma, etc. The country is looking to forge closer ties with India which has grown to be a significant player in life sciences industry globally and has now partnered with the most widely attended life sciences convention BioAsia, as the Country Partner for the 17th edition, BioAsia 2020.
Switzerland has a thriving ecosystem that’s hugely powered by innovation in academia and startups. This, coupled with the ease of doing business and policies to attract and retain talent, make Switzerland the breeding ground for cutting-edge technologies and solutions. Switzerland’s strength in healthtech is unparalleled with over 1,400 companies employing 58,500 professionals and generating CHF 15.8 Billion in revenue (in 2018). Swiss MedTech industry contributes 2.3% of the country’s GDP. The Swiss Biotech industry alone is home to 312 companies, generating a revenue of CHF 4 Billion whilst investing over CHF 1.5 Billion in R&D, yearly.
.jpeg)
